135 related articles for article (PubMed ID: 32859642)
1. Copy Number Alterations in Papillary Thyroid Carcinomas: Does Loss of
DE Almeida DCN; DE Souza MPC; Amorim CKN; DA Silva MauÉs JH; DO E Santo Sagica F; Moreira-Nunes CA; DE Oliveira EHC
Cancer Genomics Proteomics; 2020; 17(5):643-648. PubMed ID: 32859642
[TBL] [Abstract][Full Text] [Related]
2. Assessing thyroid cancer risk using polygenic risk scores.
Liyanarachchi S; Gudmundsson J; Ferkingstad E; He H; Jonasson JG; Tragante V; Asselbergs FW; Xu L; Kiemeney LA; Netea-Maier RT; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Brock P; Nabhan F; Thorleifsson G; Ringel MD; Stefansson K; de la Chapelle A
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5997-6002. PubMed ID: 32132206
[TBL] [Abstract][Full Text] [Related]
3. Novel somatic alterations underlie Chinese papillary thyroid carcinoma.
Yang C; Xu W; Gong J; Liu Z; Cui D
Cancer Biomark; 2020; 27(4):445-460. PubMed ID: 32065787
[TBL] [Abstract][Full Text] [Related]
4. DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression.
Wu X; Yan Y; Li H; Ji N; Yu T; Huang Y; Shi W; Gao L; Ma L; Hu Y
Biochem Biophys Res Commun; 2018 Sep; 503(3):1247-1253. PubMed ID: 30029886
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
[TBL] [Abstract][Full Text] [Related]
6. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
[TBL] [Abstract][Full Text] [Related]
8. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.
Choi JH; Lee J; Yang S; Lee EK; Hwangbo Y; Kim J
Sci Rep; 2018 Oct; 8(1):15004. PubMed ID: 30301923
[TBL] [Abstract][Full Text] [Related]
11. Key candidate genes associated with BRAF
Yu X; Zhong P; Han Y; Huang Q; Wang J; Jia C; Lv Z
J Cell Physiol; 2019 Dec; 234(12):23369-23378. PubMed ID: 31161615
[TBL] [Abstract][Full Text] [Related]
12. The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
Kim K; Kim JH; Park IS; Rho YS; Kwon GH; Lee DJ
World J Surg; 2018 Nov; 42(11):3624-3631. PubMed ID: 29750323
[TBL] [Abstract][Full Text] [Related]
13. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
Elisei R; Viola D; Torregrossa L; Giannini R; Romei C; Ugolini C; Molinaro E; Agate L; Biagini A; Lupi C; Valerio L; Materazzi G; Miccoli P; Piaggi P; Pinchera A; Vitti P; Basolo F
J Clin Endocrinol Metab; 2012 Dec; 97(12):4390-8. PubMed ID: 23066120
[TBL] [Abstract][Full Text] [Related]
14. Incidence of
Kure S; Ishino K; Kudo M; Wada R; Saito M; Nagaoka R; Sugitani I; Naito Z
J Int Med Res; 2019 Nov; 47(11):5560-5572. PubMed ID: 31533501
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA signature predicts survival in papillary thyroid carcinoma.
Chengfeng X; Gengming C; Junjia Z; Yunxia L
J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
Neta G; Brenner AV; Sturgis EM; Pfeiffer RM; Hutchinson AA; Aschebrook-Kilfoy B; Yeager M; Xu L; Wheeler W; Abend M; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ
Carcinogenesis; 2011 Aug; 32(8):1231-7. PubMed ID: 21642358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
